Health and Global Policy Institute

What Health and Global Policy Institute does

Health and Global Policy Institute (HGPI / 日本医療政策機構) is a Tokyo-based independent health policy think tank established in 2004 as a Specified Non-Profit Corporation (特定非営利活動法人). It convenes multi-stakeholder advisory boards across government, academia, civil society, and industry to produce evidence-based policy recommendations covering NCDs, AMR, dementia, mental health, vaccinations, planetary health, women's health, child health, and healthcare system sustainability. It operates four core platforms: NCD Alliance Japan (secretariat), AMR Alliance Japan, the Japan Health Policy NOW (JHPN) information portal, and J-PEP, a patient and public involvement platform for research and development. It runs recurring programmatic assets including the HGPI Seminar series (140+ sessions), Special Breakfast Meetings, the Healthcare Policy Academy (now in its 14th term), and a numbered HGPI Policy Column series (through No. 74).

HGPI's underlying technology is a policy research and advocacy stack rather than software. The proprietary 'Multi-stakeholder Advisory Board Framework' integrates government, academic, civil-society, and industry voices, while its 'Policy Development Methodology' combines expert hearings, public opinion surveys, and multi-stakeholder deliberation to produce actionable policy proposals. All publications are distributed free as downloadable Japanese/English PDFs via the website, and events run in hybrid (in-person Tokyo plus global Zoom webinar) format. Digital channels include an active presence across Twitter/X, Facebook, LinkedIn, Instagram, and Threads.

As a non-profit, HGPI generates revenue through individual/organizational membership fees, donations, and likely corporate sponsorship of named projects (e.g., Novo Nordisk co-sponsoring the obesity symposium, Novartis participating in cardiovascular and kidney advisory boards, AstraZeneca on planetary health). Revenue, headcount, and detailed financials are not publicly disclosed. Primary stakeholders served are Japanese national and prefectural government agencies, academic researchers, patient and civil society organizations, and healthcare industry participants.

Name

Health and Global Policy Institute

Legal name

特定非営利活動法人 日本医療政策機構

Website

https://hgpi.org

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Health and Global Policy Institute is an independent Tokyo-based health policy think tank founded in 2004 that convenes government, academia, civil society, and industry stakeholders to produce evidence-based recommendations on NCDs, AMR, dementia, planetary health, and healthcare system sustainability.

Ownership category

akta.pro rank

Product category

Health Policy Research and Advocacy

NAICS

Research and Development in the Social Sciences and Humanities (541720)

akta.pro industry

PRIMARYBPAIAJAB

Public Health Policy, Planning & Governance

Business & Public Services/Public Sector & Government Administration/Public Health Administration & Regulation

SECONDARYHLAJACAF

Health Technology Assessment (HTA) & Reimbursement Policy Bodies

Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities

SECONDARYHLAJABAN

Data Integration, Interoperability & Reporting (ELR/HIE/CDC/NNDSS)

Healthcare & Life Sciences/Public Health, Government & Regulators/Disease Surveillance, Epidemiology & Outbreak Response

Keywords

• Health policy research
• Policy advocacy
• Non-communicable diseases
• Patient engagement
• Global health policy

Headquarters

HQ city

Otemachi

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Membership fees: Membership fees for individuals and organizations supporting HGPI's policy research and advocacy activities.
2. Donations and contributions: Donations and contributions from supporters to fund independent health policy research and policy activities.

Distribution channels2 records

Marketing channels7 records

Core offering

HGPI is an independent, non-profit health policy think tank that conducts evidence-based health policy research and produces policy recommendations across domains including NCDs, AMR, dementia, mental health, vaccinations, planetary health, and healthcare system sustainability. It convenes government, academia, civil society, and industry through advisory boards, alliance platforms (NCD Alliance Japan, AMR Alliance Japan), and patient engagement initiatives (J-PEP). It disseminates recommendations through publications, seminars, and educational programs such as the Healthcare Policy Academy.

Product overview

The Health and Global Policy Institute (HGPI) is an independent health policy think tank operating primarily in Japan that does not offer traditional commercial products or software. Instead, HGPI provides policy intelligence services through collaborative projects, platforms, and publications. The organization functions through multiple thematic projects (Kidney Disease, Cardiovascular, Obesity, Dementia, Mental Health, AMR, Vaccinations, Planetary Health) that produce policy recommendations and facilitate multi-stakeholder dialogue. Key platforms include J-PEP (Japan's Patient Expert Platform) for patient involvement in research, JHPN (Japan Health Policy NOW) for policy information, and various alliance networks (NCD Alliance Japan, AMR Alliance Japan) for collaborative advocacy. HGPI also conducts educational programs (Healthcare Policy Academy) and event series (HGPI Seminars, Special Breakfast Meetings) to advance health policy discourse. The portfolio represents an integrated approach to health policy development rather than discrete product modules.

Differentiator

Problem solved

Functional benefit

Products and services

• J-PEP (Japan's Patient Expert Platform) A platform for patient and public involvement (PPI) in research and development, facilitating participation opportunities and training for patients, citizens, and researchers in Japan. Operated by HGPI and open to patient organizations, civil society, and individual participants.
• Japan Health Policy NOW (JHPN) A comprehensive online resource portal operated by HGPI that provides information about Japan's health policy landscape across multiple domains, including downloadable publications in Japanese and English.
• HGPI Policy Columns Regular policy commentary columns (No.48, 53, 54, 55, 74, etc.) addressing health policy topics including planetary health, chronic kidney disease, dementia, healthcare system issues, and AI-era policy-making.
• Kidney Disease Control Promotion Project HGPI policy project focusing on chronic kidney disease (CKD) prevention, early intervention, and cross-sectoral collaboration, including hearing-based research and policy recommendations.
• Obesity Control Promotion Project HGPI policy project addressing obesity as a chronic disease requiring multi-stakeholder collaboration and patient involvement, including a co-sponsored symposium with Novo Nordisk Pharma K.K.
• Cardiovascular Disease Control Promotion Project HGPI policy project promoting cardiovascular disease prevention and treatment through evidence-based policy recommendations, anchored by the Nationwide Summit for Promoting CVD Control engaging all 38 Japanese prefectures.
• Patient and Public Involvement (PPI) Support Project HGPI project promoting meaningful patient and citizen engagement in health policy formation processes, including recommendations submitted to government on PPI in research and development.
• NCD Alliance Japan A multi-stakeholder platform for non-communicable disease prevention and control, coordinated by HGPI as secretariat and affiliated with the global NCD Alliance network spanning roughly 170 countries and about 2,000 civil society organizations.
• AMR Alliance Japan Multi-stakeholder alliance focused on antimicrobial resistance (AMR) countermeasures, coordinated by HGPI and aligned with WHO global action plans on AMR.
• Planetary Health Project HGPI initiative addressing planetary health strategy connecting climate crisis response with human health, including multi-stakeholder advisory boards and joint statements such as the Japan-type Planetary Health Strategy declaration of 2026-06-24.
• Healthcare Policy Academy HGPI educational program (currently in its 14th series) providing training in health policy development for professionals and future leaders.
• HGPI Seminars HGPI's regular seminar series (over 140 sessions to date) discussing health policy topics with experts, conducted in hybrid in-person and online formats.
• Special Breakfast Meetings HGPI-hosted exclusive high-level discussion meetings (特別朝食会) bringing together government officials, experts, and stakeholders for closed-door health policy dialogue.

Quantifiable outcome

• 38 prefectures engaged in cardiovascular disease control policy promotion through national summits and regional meetings.
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

13 partnerships are on record, tiered core and minor.

• AstraZeneca JapancoreStrategic or Co-development Partner · 24 June 2026AstraZeneca Japan participates as a member in HGPI's Planetary Health project advisory board, contributing to joint statements and policy recommendations on planetary health strategy. Representatives from AstraZeneca's sustainability and policy affairs divisions contribute to multi-stakeholder policy deliberation.
• Japan Medical Association (日本医師会)coreStrategic or Co-development Partner · 24 June 2026The Japan Medical Association is listed among the advisory board members contributing to the joint statement on planetary health strategy. Association representatives participate in multi-stakeholder policy development discussions.
• Japan Development Bank (日本政策投資銀行)minorStrategic or Co-development Partner · 24 June 2026The Japan Development Bank's Healthcare Division Head participates in HGPI's Planetary Health advisory board, contributing financial and economic expertise to health policy recommendations.
• MS&AD Insurance Group HoldingsminorStrategic or Co-development Partner · 24 June 2026MS&AD Insurance Group Holdings participates in HGPI's Planetary Health project as a sustainability advisory board member, contributing insurance and sustainability sector perspectives.
• Asian Development Bank (ADB)coreStrategic or Co-development Partner · 24 June 2026ADB's health specialist participates in HGPI's Planetary Health advisory board, contributing international development finance perspective to Japan's planetary health strategy discussions.
• NCD Alliance Japan (NCDアライアンス・ジャパン)coreStrategic or Co-development Partner · 24 June 2026HGPI serves as the secretariat for NCD Alliance Japan, a multi-stakeholder platform coordinating civil society engagement in NCD policy across Japan. NCD Alliance Japan is affiliated with the global NCD Alliance network spanning ~170 countries and ~2,000 civil society organizations.
• AMR Alliance Japan (AMRアライアンス・ジャパン)coreStrategic or Co-development Partner · 24 June 2026HGPI participates in or hosts AMR Alliance Japan, a multi-stakeholder alliance coordinating Japan's antimicrobial resistance policy response, aligned with WHO global action plans.
• Japan Health Policy NOW (JHPN)coreStrategic or Co-development Partner · 24 June 2026HGPI operates the Japan Health Policy NOW (JHPN) portal, a comprehensive online resource tracking Japanese health policy developments across multiple domains.
• J-PEP - Japan's Patient Expert Platform (みんなの患者・当事者参画プラットフォーム)coreStrategic or Co-development Partner · 24 June 2026HGPI operates J-PEP (Japan's Patient Expert Platform), a patient and citizen involvement platform enabling participation in research and development policy. The platform conducts regular seminars and provides information on involvement opportunities.
• The Health Policy Partnership (UK)minorStrategic or Co-development Partner · 24 June 2026HGPI co-hosted a joint seminar with the UK-based Health Policy Partnership on patient and public involvement in health policy-making, facilitating international knowledge exchange.
• Novartis Pharma K.K.coreStrategic or Co-development Partner · 24 June 2026Novartis Pharma K.K. participates as an advisory board member in HGPI's cardiovascular disease and kidney disease projects, contributing pharmaceutical industry perspectives to multi-stakeholder policy discussions.
• Novo Nordisk Pharma K.K.coreStrategic or Co-development Partner · 24 June 2026Novo Nordisk Pharma K.K. co-sponsored HGPI's obesity control symposium and participates as an advisory board member in the obesity project, contributing pharmaceutical industry and lifestyle disease expertise.
• World Health Organization (WHO)coreStrategic or Co-development Partner · 24 June 2026HGPI collaborates with WHO on multiple fronts including endorsing WHO Civil Society Commission's recommendations on sustainable health financing, participating in WHO ATACH initiatives on climate and health, and engaging in global health architecture discussions.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Wellcome Trust: UK-based charitable foundation that funds and conducts independent health research and policy work, including on AMR and global health. Comparable in independent health policy advocacy mission, with substantially larger resources and broader mandate.
• Chatham House (Royal Institute of International Affairs): UK-based global affairs think tank with a Centre on Global Health that convenes multi-stakeholder policy dialogue. Broader than HGPI in scope but comparable in independent think tank model and convening role on global health issues.
• Kaiser Family Foundation (KFF): US non-profit focusing on health policy research, polling, and journalism. Highly comparable in producing independent health policy analysis and public opinion surveys, but operates at much larger scale and US-focused.
• RAND Corporation: US-based non-profit policy research organization conducting rigorous analysis on health, among other domains. Comparable in non-profit independent research model but operates at substantially larger scale and with broader geographic footprint.
• Brookings Institution: US-based public policy think tank with a robust health policy program producing independent research and convening. Comparable as a non-partisan think tank shaping policy through research and convening.

Direct peers

• NCD Alliance: Global umbrella organization for non-communicable disease civil society; HGPI hosts NCD Alliance Japan as a national affiliate. Direct functional peer on multi-stakeholder NCD policy advocacy with global coordination scope.
• Center for Global Development (CGD): Independent non-profit policy think tank producing research and recommendations on global health, development finance, and aid effectiveness. Direct peer in producing evidence-based health policy recommendations with international engagement.
• The Health Policy Partnership: UK-based health policy think tank that co-hosted a joint seminar with HGPI on patient and public involvement. Operates the same multi-stakeholder model producing policy recommendations across disease areas, making it the closest international peer.

Emerging players

• AMR Alliance (international networks): International networks coordinating civil society response to antimicrobial resistance. HGPI hosts AMR Alliance Japan, making it both a peer and affiliate in this thematic area with strong overlap on AMR policy advocacy.

Others

• World Economic Forum - Health and Healthcare Community: International organization for public-private cooperation with a dedicated health and healthcare agenda that convenes stakeholders and produces policy frameworks. Adjacent as a multi-stakeholder convening platform rather than direct peer.

Market position

Strengths5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/hgpi_2004
• Facebookfacebook.com/hgpi.org
• LinkedInjp.linkedin.com/company/health-and-global-policy-institute
• Instagraminstagram.com/hgpi_2004

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health and Global Policy Institute